Marder S R, Mebane A, Chien C P, Winslade W J, Swann E, Van Putten T
Am J Psychiatry. 1983 Apr;140(4):470-2. doi: 10.1176/ajp.140.4.470.
A recently enacted regulation in California requires that voluntary mental patients give signed informed consent for treatment with antipsychotic drugs. To evaluate the law's effects on schizophrenic patients, the authors compared 15 patients who refused to give consent with a matched group of 15 who gave consent. Refusers had significantly higher scores on the Brief Psychiatric Rating Scale for conceptual disorganization, emotional withdrawal, and unusual thought content. They were also more hostile, uncooperative, and mistrustful of the treatment team and more likely to believe they were not ill. The authors raise questions regarding the most appropriate consent process for schizophrenic patients.
加利福尼亚州最近颁布的一项规定要求，自愿接受治疗的精神病患者需签署使用抗精神病药物治疗的知情同意书。为评估该法律对精神分裂症患者的影响，作者将15名拒绝签署同意书的患者与15名签署同意书的配对患者进行了比较。在简易精神状况检查表中，拒绝签署同意书的患者在概念紊乱、情感退缩和异常思维内容方面得分显著更高。他们也更具敌意、不合作，对治疗团队不信任，并且更有可能认为自己没有患病。作者针对精神分裂症患者最恰当的同意程序提出了疑问。
